Clinical Trials
21 trialsNCT06465017 2026-04-20
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Phase NA Terminated
NCT07479381 2026-04-09
CLEAR
Harbinger Health
Terminated
NCT05348889 2025-02-13
First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies
Chimagen Biosciences, Ltd
Phase 1/2 Terminated
NCT03465579 2025-01-30
BIOPSTAGE
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase NA Terminated
NCT02666599 2024-06-20
Per-operating Use of a Probe for Detection of β+
University of Lausanne Hospitals
Phase NA Terminated
NCT03151057 2024-03-12
Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT05641324 2024-02-12
A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Anaveon AG
Phase 1 Terminated
NCT02940041 2023-12-26
CERTUM
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Terminated
NCT00633958 2021-10-20
FLT
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT03335059 2020-04-15
RITE-USA
Medical Enterprises Ltd.
Phase 3 Terminated
NCT03185182 2019-06-21
RCCSCAN
Region Skane
Phase 2 Terminated
NCT01659099 2018-03-07
GAINED
The Lymphoma Academic Research Organisation
Phase 3 Terminated
NCT02456051 2017-11-20
PaCANOD
University of Roma La Sapienza
Terminated
NCT01217489 2017-10-12
Signascan
Oxford University Hospitals NHS Trust
Terminated
NCT02042053 2017-07-18
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
NYU Langone Health
Phase NA Terminated
NCT02359500 2017-05-03
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)
Icahn School of Medicine at Mount Sinai
Phase 1 Terminated
NCT02218502 2017-03-28
SUBSONiC
Maastricht University Medical Center
Phase NA Terminated
NCT01898273 2015-09-09
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Cellectar Biosciences, Inc.
Phase 2 Terminated
NCT01009866 2015-03-20
MR1-1
Duke University
Phase 1 Terminated
NCT01007890 2012-10-05
PT-304
Precision Therapeutics
Terminated
NCT00420862 2007-01-11
The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography
Istituto Clinico Humanitas
Phase 3 Terminated